George Clinical renal research experts and scientific leaders will be on hand for the 5th Chronic Kidney Disease Drug Development Summit in Boston March 7–9. Contact Matthew Reabold or your business development lead to book a meeting.
After multiple years as a virtual-only event, CKD promises to put a spotlight on untapped pathways for therapeutic intervention, establishing a well-defined pathway in rare disease, and constructing robust clinical programs to shorten clinical trials.
George Clinical Chief Medical Officer Maria Ali, scientific leader’s Hiddo Heerspink and Roberto Pecoits-Filho and Vice President, Head of Clinical Renal AstraZeneca, Jerome Rossert will lead a high-profile panel discussion during the summit entitled Global Kidney Patients Trial Network (GKPTN): A paradigm shift in the conduct of renal studies. Keeping with the mission of CKD this year, the panel will address: how the industry can more efficiently execute renal studies, including how the novel Global Kidney Patient Trials Network (GKPTN) could directly address protocol, recruitment and execution synergies.
The summit will also focus on five major themes of vital interest to industry members:
Maria serves as the Chief Medical Officer for George Clinical, responsible for continuing to build the organization’s enviable network of investigators and scientific leaders. Previously, she led the medical and safety services group at George Clinical who provide safety management, endpoint adjudication, medical monitoring and scientific leadership for both commercially sponsored and academic clinical trials. Maria has worked closely with the scientific leads at the George Institute to develop and implement scientific leadership models for George Clinical studies, as well as to develop new ideas for clinical research, and processes to improve clinical trial design and efficiencies. Maria has several years’ experience in both public health and clinical research as well as research management across a range of settings including hospitals, academic and clinical research organizations.
Professor Heerspink’s principal research interests include optimizing current treatment strategies and finding new therapeutic approaches to halt the progression of renal and cardiovascular disease in patients with diabetes with a specific focus on personalized medicine. He is Professor of Clinical Trials and Personalized Medicine; Clinical Pharmacologist at the Department of Clinical Pharmacy and Pharmacology at the University Medical Center Groningen, the Netherlands; and visiting professor at the University of New South Wales in Sydney. He worked as a Postdoctoral Fellow at The George Institute for Global Health, Sydney, Australia, where he investigated the effects of blood pressure-lowering regimens on renal and cardiovascular outcomes in patients with chronic kidney disease.
Professor Heerspink leads and participates in clinical trials focused on renal and cardiovascular complications of Type 2 diabetes. His main expertise includes clinical trial design and personalized medicine as well as methodological aspects and statistical analyses of clinical trials. Based on his work at The George Institute, he was awarded a young investigator grant and subsequently in 2015 a consolidator investigator grant from the Dutch organization of scientific research and received in 2016 the Galien award for his research.
Dr. Pecoits-Filho’s research is focused on chronic kidney disease and he is currently a Visiting Researcher at The George Institute for Global Health, Sydney. He was a member of the Executive Committee of KDIGO and the International Society of Nephrology (ISN) and is currently the chair of the ISN Education Working Group, and part of the Core Group of ISN’s Advancing Clinical Trials Initiative. He is Senior Research Scientist at Arbor Research collaborative for Health; Professor of Medicine at the Pontifical Catholic University of Paraná in Brazil; and a practicing nephrologist.
Dr. Pecoits-Filho has played an active role in study design, implementation, coordination, event adjudication, data management and data monitoring safety for various trials. His participation in clinical trials includes as Principal Investigator, National Leader and Chair or member of steering committees. He has been featured in a series of ISN podcasts covering the diverse topics related to the field of nephrology and current issues that impact nephrologists around the world.
Meet with George Clinical! Contact us to schedule a time now.